Synonyms | BDBM50101853 ONO 1608 Prestwick2_001018 BRD-K52459643-001-10-2 (-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoate
Prostaglandin E1 Caverject Impulse (13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprost-13-enoate Prostaglandin-E1 Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, l- 11,15-dihydroxy-9-oxoprost-13-en-1-oic acid (ACD/Name 4.0) RayVa DTXSID9022578 50-83-9 SMR000112594 GMVPRGQOIOIIMI-DWKJAMRDSA-N 745-65-3 Sugiran HMS2090L08 AB2000131 Vasaprostan K274 Alprostadil (JP17/USP/INN) MFCD00077860 Alprostadilum Muse (TN) NCGC00025234-02 PGE1 BG0025 Prink (TN) BSPBio_001488 (11?,13E,15S)-11,15-Dihydroxy-9-oxo-prost-13-en-1-oic acid Prostaglandin E1, >=99.0% (TLC) (13e)-(15s)-11alpha,15-dihydroxy-9-oxoprost-13-enoic acid Prostavasin D0N2EF SAM001246840 EINECS 212-017-2 7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid SR-01000597593-5 HMS1361K10 AB0014134 Tox21_110482 HMS3402K10 AI3-62116 Vitaros (TN) l-Prostaglandin E1 Alprostadil(Caverject) MLS001424250 AS-16360 BCP01740 NCGC00025234-05 PGE1;Prostaglandin E1 BPBio1_001293 (+)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoate Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)- Caverject (13E)-(15S)-11,15-dihydroxy-9-oxoprost-13-enoate Prostaglandin E1; PGE1 CS-1905 11,15-Dihydroxy-9-oxoprost-13-en-1-oate Prostin VR pediatric (TN) DSSTox_GSID_22578 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid SCHEMBL33317 FemLife 7-[(1r,3r)-3-Hydroxy-2-[(1e,3s)-3-Hydroxyoct-1-En-1-Yl]-5-Oxocyclopentyl]heptanoic Acid SR-01000946253-1 HMS1989K10 AB00514004-08 U-10136 HY-B0131 ZINC3813088 Liprostin Alprostadil, meets USP testing specifications MR-256 NC00438 Befar Prestwick3_001018 BRD-K52459643-001-17-7 (-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid Prostaglandin E1, 98+% CCG-101188 (13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprost-13-enoic acid Prostaglandine E D00180 119314-69-1 RP17688 Edex SR-01000597593 GTPL1882 745P653 SYN3025 HMS2098K17 AC-6095 Viridal l-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid Alprostadil Prostoglandin E1 Minprog Alprostadilum [INN-Latin] NCGC00025234-03 PGE1 Oligomer BIDD:GT0747 Promostan C04741 (11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid Prostaglandin E1, powder, gamma-irradiated, BioXtra, suitable for cell culture CHEMBL495 (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid Prostin VR 22299-37-2 SAM001246845 EX-A1411 7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid SR-01000597593-6 HMS1571K17 AB00514004 U 10136 HMS3648O17 AKOS015961103 W-104416 Lipo-alprostadil Alprostadil(usan) MolPort-003-939-183 B2154 BCP9000277 NSC 165559 PGE1alpha BRD-K52459643-001-06-0 (+)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-, homopolymer Caverject (TN) (13E)-(15S)-11,15-dihydroxy-9-oxoprost-13-enoic acid Prostaglandin E1;Edex;Muse;Liprostin;Caverject Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, (-)- 11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid Prostivas DSSTox_RID_76640 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid SMP2_000271 Femprox 7-[5-((1E)(3S)-3-hydroxyoct-1-enyl)(1R,4R,5R)-4-hydroxy-2-oxocyclopentyl]hepta noic acid ST50826271 HMS2052L11 AB00514004_09 UNII-F5TD010360 IDI1_033958 Alprostadil (JP15/USP/INN) LMFA03010134 Alprostadil, United States Pharmacopeia (USP) Reference Standard Muse NCGC00016535-01 PGE-1 Befar (TN) Prink BSPBio_001175 (-)-Protaglandin E1 Prostaglandin E1, >=98% (HPLC), synthetic CHEBI:15544 (13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate Prostandin D0I4DQ 11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid s1508 Edex (TN) 50865-30-0 SR-01000597593-1 HEI-507 9-oxo-11R,15S-dihydroxy-13E-prostaenoic acid Topiglan HMS3268I09 AC1NQXHQ Vitaros l-PGE1 Alprostadil [USAN:USP:INN:BAN:JAN] MLS000758964 Alprox-TD NCGC00025234-04 PGE1, Prostaglandin E1, powder BML1-F06 Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11.alpha.,13E,15S)- CAS-745-65-3 (11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid Prostaglandin E1, synthetic, powder, BioReagent, suitable for cell culture CPD000112594 (1R,2R,3R)-3-Hydroxy-2-((E)-(3S)-3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid Prostin VR Pediatric DSSTox_CID_2578 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate SAM001247093 F5TD010360 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid SR-01000946253 HMS1791K10 AB00514004-06 U-10,136 HMS3715K17 Alista XPG Lipoprost Alprostadil, European Pharmacopoeia (EP) Reference Standard MR 256 BC205461 [ Show all ] |
---|